Login / Signup

Real world treatment patterns, healthcare resource use and costs in patients with advanced or metastatic non-small cell lung cancer by EGFR mutation type.

Pratyusha VadagamDexter WatersInyoung LeeJustin ChenDajun TianAimee M NearDerek LyleJulie Vanderpoel
Published in: Journal of medical economics (2024)
mutation types and were highest among exon20i cohort, potentially reflecting higher disease burden and unmet need among patients with this mutation.
Keyphrases
  • healthcare
  • small cell lung cancer
  • squamous cell carcinoma
  • epidermal growth factor receptor
  • tyrosine kinase
  • risk factors